Get the Stockscreener App
3.16
21.09%
-0.87
Sonnet Biotherapeutics Holdings Inc stock is traded at $3.16, with a volume of 728.80K.
It is down -21.09% in the last 24 hours and down -43.52% over the past month.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
See More
Previous Close:
$4.03
Open:
$4.04
24h Volume:
728.80K
Relative Volume:
0.84
Market Cap:
$21.57M
Revenue:
$129.20K
Net Income/Loss:
$-7.44M
P/E Ratio:
-0.2824
EPS:
-11.19
Net Cash Flow:
$-8.62M
1W Performance:
-34.97%
1M Performance:
-43.52%
6M Performance:
+133.82%
1Y Performance:
-26.56%
1-Day Range:
$3.12
$4.0699
1-Week Range:
$3.12
$5.16
52-Week Range:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Name
Sonnet Biotherapeutics Holdings Inc
Sector
Industry
Phone
609-375-2227
Address
100 OVERLOOK CENTER, PRINCETON, NJ
Compare SONN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
3.16 | 27.51M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.60 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.82 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.38 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Latest News
Published on: 2025-11-04 05:20:37 - newser.com
What momentum shifts mean for Sonnet BioTherapeutics Holdings Inc.Market Volume Report & Fast Exit/Entry Strategy Plans - newser.com
What analysts say about Sonnet BioTherapeutics Holdings Inc stockSupport Level Holds & Invest Smarter With Signals - earlytimes.in
Will Sonnet BioTherapeutics Holdings Inc. stock reach Wall Street targetsJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Sentiment analysis tools applied to Sonnet BioTherapeutics Holdings Inc. - newser.com
Regression analysis insights on Sonnet BioTherapeutics Holdings Inc. performanceBuy Signal & Consistent Return Investment Signals - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock outperform in 2025 bull marketEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
What high frequency data says about Sonnet BioTherapeutics Holdings Inc.2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com
Chart based analysis of Sonnet BioTherapeutics Holdings Inc. trendsMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Detecting price anomalies in Sonnet BioTherapeutics Holdings Inc. with AISwing Trade & Real-Time Volume Triggers - newser.com
What recovery options are there for Sonnet BioTherapeutics Holdings Inc.July 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What sentiment indicators say about Sonnet BioTherapeutics Holdings Inc. stockJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Will Sonnet BioTherapeutics Holdings Inc. outperform the marketJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Momentum divergence signals in Sonnet BioTherapeutics Holdings Inc. chartJuly 2025 Movers & AI Optimized Trade Strategies - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock sustain revenue growth2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
Can technical indicators confirm Sonnet BioTherapeutics Holdings Inc.’s reversalPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Published on: 2025-11-02 23:39:05 - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock trading at a premium valuationDollar Strength & Safe Swing Trade Setup Alerts - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock a good choice for value investors - newser.com
How to manage a losing position in Sonnet BioTherapeutics Holdings Inc.2025 Biggest Moves & Community Consensus Picks - newser.com
Applying big data sentiment scoring on Sonnet BioTherapeutics Holdings Inc.2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Applying sector rotation models to Sonnet BioTherapeutics Holdings Inc.July 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Tools to assess Sonnet BioTherapeutics Holdings Inc.’s risk profileWatch List & AI Driven Stock Price Forecasts - newser.com
Predicting Sonnet BioTherapeutics Holdings Inc. trend using moving averagesJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
Using data models to predict Sonnet BioTherapeutics Holdings Inc. stock movementJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
What technical charts say about Sonnet BioTherapeutics Holdings Inc. stockJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-10-31 04:49:13 - newser.com
How Sonnet BioTherapeutics Holdings Inc. stock reacts to global recession fearsJuly 2025 Sector Moves & Fast Gain Stock Tips - newser.com
Published on: 2025-11-04 03:56:51 - newser.com
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):